Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|July 15, 2026
Choline PET/CT in the PSMA Era: Clinical Repositioning, Biological Perspectives, and Emerging ApplicationsVirginia Rossetti, Lorenzo Fantini, Irene Marini, et al.
JOP : Journal of the Pancreas|September 28, 2005
Echo-enhanced ultrasonography: is it the future gold standard of imaging in acute pancreatitis?Emilio Brocchi, Fabio Piscaglia, Miriam Bonora, et al.
Anti-Cancer Drugs|June 28, 2016
Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcomaGiacomo G Baldi, Samantha Di Donato, Rossana Fargnoli, et al.
Cancer Treatment and Research Communications|March 14, 2026
PSMA for HCC: a new frontier in precision medicine for liver cancer?Paola Caroli, Virginia Rossetti, Maddalena Sansovini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary resultsCristina Nanni, Costantino Errani, Luca Boriani, et al.
Digestive Diseases and Sciences|May 1, 2007
Fecal calprotectin levels in patients with colonic polyposisRaffaele Pezzilli, Alessandra Barassi, Antonio M Morselli Labate, et al.
Journal of Gastroenterology|September 19, 2007
Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammationRaffaele Pezzilli, Alessandra Barassi, Antonio M Morselli-Labate, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2017
Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary resultsFederica Matteucci, Emilio Mezzenga, Paola Caroli, et al.
Pancreas|June 27, 2008
Serum adhesion molecules in acute pancreatitis: time course and early assessment of disease severityRaffaele Pezzilli, Massimiliano M Corsi, Alessandra Barassi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2017
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamidePaola Caroli, Ugo De Giorgi, Emanuela Scarpi, et al.
Pageof 3